Company Analysis
Sign in

Alnylam Pharmaceuticals, Inc. (ALNY)

Nasdaq: ALNY · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 2002
Full chart Alerts Compare
Grade6.8
◀ Past 7.0● Present 7.0▶ Future 6.3
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 12, 2026Feb 13, 2025Feb 15, 2024Feb 23, 2023Feb 10, 2022Feb 11, 2021Feb 13, 2020Feb 14, 2019Feb 15, 2018Feb 15, 2017
Revenue3,713,9372,248,2431,828,2921,037,418844,287492,853219,75074,90889,91247,159
Cost of revenue677,166306,513268,216140,174115,00574,185r25,0621,8020·
Research and development1,319,7751,126,2321,004,415883,015792,156654,819655,114505,420390,635382,392
Selling, general and administrative1,210,713975,526795,646770,658620,639588,420479,005382,359199,36589,354
General and administrative········199,36589,354
Total operating expenses········590,000471,746
Total costs and expenses3,212,3592,425,1282,110,4671,822,4901,552,9391,321,2911,159,181889,581590,000471,746
Operating income501,578-176,885-282,175-785,072-708,652-828,438-939,431-814,673-500,088-424,587
Interest expense252,627141,858121,221155,968143,02184,49600··
Interest and investment income111,470121,99295,56124,8081,57911,80933,44829,26212,2368,308
Other income (expense), net5,204-180,624-125,682-134,175r-2,05057,334r20,730r24,737r-3,0226,171
Total non-operating income (expense)-178,426-200,490-151,342-341,921-143,492-27,16254,17853,9999,21414,479
Income before income taxes323,152-377,375-433,517-1,126,993-852,144-855,600-885,253-760,674-490,874-410,108
Income tax expense9,405-99,2186,7254,1636802,68186382300
Net income including non-controlling interests···-1,131,156-852,824-858,281-886,116-761,497-490,874-410,108
Net income313,747-278,157-440,242-1,131,156-852,824-858,281-886,116-761,497-490,874-410,108
Earnings per share, basic2.39-2.18-3.52-9.30-7.20-7.46-8.11···
Earnings per share, diluted2.33-2.18-3.52-9.30-7.20-7.46-8.11···
Earnings per share, basic and diluted·····-7.46-8.11-7.57-5.42-4.79
Weighted average shares, basic131,004127,651124,906121,689118,451114,986109,264···
Weighted average shares, diluted134,684127,651124,906121,689118,451114,986109,264···
Weighted average shares, basic and diluted·····114,986109,264100,59090,55485,596
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
us-gaap:InvestmentIncomeNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton ALNY · research, not advice